Zubkov Alexander Y, Rabinstein Alejandro A, Dispenzieri Angela, Wijdicks Eelco F M
Mayo Clinic, Department of Neurology, Rochester, MN 55901, USA.
Neurology. 2007 Sep 11;69(11):1136-41. doi: 10.1212/01.wnl.0000276951.39112.2b.
Amyloidosis is an uncommon disorder that ultimately leads to fatal multiorgan failure. Ischemic strokes have been sporadically described but are not well characterized. The purpose of this study was to review the pathophysiologic relationship between primary systemic amyloidosis and ischemic stroke, and to determine how often stroke is the first defining manifestation.
Retrospective study of 49 patients with confirmed primary amyloidosis and ischemic stroke. All included patients had biopsy proven amyloidosis.
Forty patients were included in the study. Ischemic strokes occurred in 13 patients (32.5%) as the initial presentation of amyloidosis. Patients with initial stroke presentation had the worst outcome, with average survival of 6.9 months after established diagnosis with amyloidosis; strokes developed 9.6 months before diagnosis with primary amyloidosis. Thirty-seven percent experienced recurrent ischemic stroke. The majority (70%) of patients had cardioembolic infarctions.
Ischemic stroke is an underappreciated complication of primary amyloidosis. In the absence of obvious clinical and cardiogenic manifestations, primary amyloidosis should be considered when echocardiography demonstrates thickening of the valves, restrictive pattern, and increased echogenicity. Ischemic strokes as an initial presentation of primary amyloidosis carries a worse prognosis.
淀粉样变性是一种罕见疾病,最终会导致致命的多器官功能衰竭。缺血性中风虽有零星报道,但特征描述并不充分。本研究旨在回顾原发性系统性淀粉样变性与缺血性中风之间的病理生理关系,并确定中风作为首发明确表现的频率。
对49例确诊为原发性淀粉样变性合并缺血性中风的患者进行回顾性研究。所有纳入患者均经活检证实为淀粉样变性。
40例患者纳入研究。13例患者(32.5%)的缺血性中风为淀粉样变性的首发表现。以中风为首发表现的患者预后最差,确诊淀粉样变性后平均存活6.9个月;中风发生在原发性淀粉样变性确诊前9.6个月。37%的患者发生复发性缺血性中风。大多数患者(70%)为心源性梗死。
缺血性中风是原发性淀粉样变性一种未得到充分认识的并发症。在没有明显临床和心源性表现的情况下,当超声心动图显示瓣膜增厚、限制性模式和回声增强时,应考虑原发性淀粉样变性。缺血性中风作为原发性淀粉样变性的首发表现预后较差。